SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 130 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $60,178,000 | +22.4% | 9,881,438 | +10.7% | 0.01% | +10.0% |
Q3 2016 | $49,180,000 | +46.7% | 8,925,527 | +1.1% | 0.01% | +42.9% |
Q2 2016 | $33,533,000 | +113.0% | 8,824,549 | +54.7% | 0.01% | +75.0% |
Q1 2016 | $15,742,000 | -47.7% | 5,703,801 | +7.4% | 0.00% | -42.9% |
Q4 2015 | $30,113,000 | +2.7% | 5,310,885 | -4.0% | 0.01% | -12.5% |
Q3 2015 | $29,309,000 | -10.4% | 5,529,916 | +40.3% | 0.01% | 0.0% |
Q2 2015 | $32,713,000 | +84.0% | 3,941,283 | +2.4% | 0.01% | +100.0% |
Q1 2015 | $17,778,000 | +54.1% | 3,847,965 | +1.7% | 0.00% | +33.3% |
Q4 2014 | $11,537,000 | +21.3% | 3,782,497 | +10.8% | 0.00% | 0.0% |
Q3 2014 | $9,511,000 | -31.6% | 3,415,145 | -0.1% | 0.00% | -25.0% |
Q2 2014 | $13,913,000 | -22.2% | 3,418,498 | +1.5% | 0.00% | -20.0% |
Q1 2014 | $17,889,000 | -1.7% | 3,368,927 | +4.2% | 0.01% | -16.7% |
Q4 2013 | $18,207,000 | +22.4% | 3,233,847 | -0.6% | 0.01% | +20.0% |
Q3 2013 | $14,873,000 | +21.1% | 3,254,456 | +14.5% | 0.01% | 0.0% |
Q2 2013 | $12,280,000 | – | 2,842,581 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |